|
Volumn 54, Issue 3, 2011, Pages 572-576
|
Evaluation of a synthetic peptide as a replacement for the recombinant fusion protein of respiratory syncytial virus in a potency ELISA
|
Author keywords
ELISA; F protein; Monoclonal antibody; Respiratory syncytial virus; Surface plasmon resonance
|
Indexed keywords
GLYCOPROTEIN;
GLYCOPROTEIN F;
MOTAVIZUMAB;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING AFFINITY;
CLINICAL EVALUATION;
CONTROLLED STUDY;
DRUG DEGRADATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HEP 2 CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN SECRETION;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
SENSITIVITY ANALYSIS;
SURFACE PLASMON RESONANCE;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTIBODY AFFINITY;
ANTIVIRAL AGENTS;
CHROMATOGRAPHY, GEL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EPITOPES;
HUMANS;
PEPTIDE FRAGMENTS;
RECOMBINANT FUSION PROTEINS;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUSES;
SURFACE PLASMON RESONANCE;
VIRAL FUSION PROTEINS;
|
EID: 78149501024
PISSN: 07317085
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jpba.2010.09.008 Document Type: Article |
Times cited : (4)
|
References (17)
|